SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-006775
Filing Date
2019-03-07
Accepted
2019-03-07 16:10:16
Documents
3
Period of Report
2019-03-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K omed-8k_20190307.htm 8-K 31537
2 EX-99.1 omed-ex991_6.htm EX-99.1 271655
3 GRAPHIC gde32genoc11000001.jpg GRAPHIC 3404
  Complete submission text file 0001564590-19-006775.txt   309141
Mailing Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-995-8200
OncoMed Pharmaceuticals Inc (Filer) CIK: 0001302573 (see all company filings)

IRS No.: 383572512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35993 | Film No.: 19665944
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences